[ad_1]
Founded in the 1990s by Late Shyamsunder Taparia, Jaiprakash Taparia and family, Pregna is a contraception devices maker in the global IUD (intrauterine devices) space with a growing portfolio of reproductive and women’s health products. Pregna has a presence in over 140 countries and is the largest IUD manufacturer in the world. The company is led by Mukul Taparia.
“Pregna has developed strong capabilities in new product development, Class III Medical Devices manufacturing, long-term drug delivery applications, and global market reach. Together with ILSF III, we intend to strengthen and leverage these capabilities and provide access to high-quality innovative reproductive health products to women worldwide,” said Mukul Taparia, Managing Director of Pregna.
India Life Sciences Fund is a family of funds that have so far raised $500 million from global investors since 2007. InvAscent is the investment advisor to the India Life Sciences Funds. The funds have deployed capital in over 30 companies across pharma, healthcare delivery, medical devices, and animal health sectors.
“Pregna is renowned for its innovative solutions for women’s health. This investment will fuel Pregna’s growth and enable them to address the evolving needs of women across the globe,” siad Sumit Gupta, Managing Director at InvAscent.
Investment banker Unaprime Investment Advisors acted as the exclusive financial advisor to Pregna for this transaction.“Pregna has built its global presence and scale over time and remains one of the top Intra Uterine Device (IUD) manufacturers globally. The company is well-positioned to capitalize on its enhanced manufacturing capabilities, expanding product portfolio, and geographical reach. India Life Sciences Fund III is thrilled to collaborate with Pregna and its founders in their ambitious goal of becoming a prominent global player in the field of women’s reproductive health,” said Anil Jagirdar, Vice President – Investments, InvAscent.
[ad_2]
Source link